The medical landscape for blood sugar is changing, and transdermal GLP-1 delivery systems represent a potential breakthrough. Unlike injections, this approach offers a more convenient way to administer GLP-1 drugs. These devices gradually release the treatment through the epidermis offering a even level of the active agent, which can enhance blood